$6.47
-0.62-9.58%
At close: Dec 24, 9:29 AM EDT
$5.85
-0.62-9.58%
After Hours: Dec 24, 9:29 AM EDT
15 minutes delayed
Sinovac Biotech reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Sinovac Biotech using advanced sorting and filters.
Get Alert | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
SVA | Sinovac Biotech | $4.24 | — | — | — | $12.12B | — | — | — | 07/16/2024 | Get Alert |
SVA | Sinovac Biotech | -$0.37 | -$0.13 | — | — | $1.49B | $0.00 | — | — | 07/16/2024 | Get Alert |
SVA | Sinovac Biotech | $74.27 | — | -$0.37 | — | $19.38B | — | $1.49B | — | 05/01/2023 | Get Alert |
SVA | Sinovac Biotech | $44.78 | — | $4.24 | — | $10.98M | — | $12.12B | — | 12/29/2022 | Get Alert |
SVA | Sinovac Biotech | $0.97 | — | $74.27 | — | $510.62M | — | $19.38B | — | 04/29/2022 | Get Alert |
SVA | Sinovac Biotech | — | — | $44.78 | — | — | — | $10.98B | — | 12/30/2021 | Get Alert |
SVA | Sinovac Biotech | $0.21 | — | $0.96 | — | $81.11M | — | $327.45M | — | 04/22/2021 | Get Alert |
SVA | Sinovac Biotech | $0.19 | — | $0.10 | — | $64.30M | — | $115.45M | — | 12/07/2020 | Get Alert |
SVA | Sinovac Biotech | $0.12 | — | -$0.05 | — | $64.05M | — | $52.33M | — | 08/28/2020 | Get Alert |
SVA | Sinovac Biotech | $0.01 | — | -$0.07 | — | $36.55M | — | $15.39M | — | 06/30/2020 | Get Alert |
SVA | Sinovac Biotech | — | — | $0.21 | — | — | — | $81.11M | — | 04/30/2020 | Get Alert |
SVA | Sinovac Biotech | $0.36 | — | $0.19 | — | $53.90M | — | $64.30M | — | 11/15/2019 | Get Alert |
SVA | Sinovac Biotech | — | — | $0.12 | — | — | — | $64.05M | — | 08/15/2019 | Get Alert |
SVA | Sinovac Biotech | — | — | $0.01 | — | — | — | $36.55M | — | 07/10/2019 | Get Alert |
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Sinovac Biotech (SVA) is scheduled to report earnings on July 16, 2024. The last reported earnings were for reported on May 1, 2023 for FY.
The Actual EPS was $-0.37, which missed the estimate of $0.00.
The Actual Revenue was $1.5B, which beat the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.